Actively Recruiting
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
Led by Al-Azhar University · Updated on 2024-09-19
18
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.
CONDITIONS
Official Title
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 30 years
- Patients with good oral hygiene
- Patients free from systemic diseases that may affect therapy outcome
- Patients with horizontal bone defects classified as Class III or IV
You will not qualify if you...
- Heavy smokers
- Patients treated with immunosuppressive chemotherapy or radiotherapy
- Allergy to any material or medication used in the study
- Pregnant females
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al Azhar University of Cairo
Cairo, Nasr City, Egypt
Actively Recruiting
Research Team
M
Mahmoud Taha, PHD
CONTACT
I
Ibrahim Sabri
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here